
Research Article
Comparative Analysis of Logistic Regression and Random Forest Models for Cardiovascular Disease Prediction Using Clinical Data
@INPROCEEDINGS{10.4108/eai.22-5-2026.2365083, author={Keliang Li}, title={Comparative Analysis of Logistic Regression and Random Forest Models for Cardiovascular Disease Prediction Using Clinical Data}, proceedings={Proceedings of the 4th International Conference on Image, Algorithms, and Artificial Intelligence, ICIAAI 2026, 22-24 May 2026, Singapore, Singapore}, publisher={EAI}, proceedings_a={ICIAAI}, year={2026}, month={8}, keywords={Cardiovascular disease; Machine learning; Logistic regression; Random forest; Clinical risk prediction}, doi={10.4108/eai.22-5-2026.2365083} }- Keliang Li
Year: 2026
Comparative Analysis of Logistic Regression and Random Forest Models for Cardiovascular Disease Prediction Using Clinical Data
ICIAAI
EAI
DOI: 10.4108/eai.22-5-2026.2365083
Abstract
Cardiovascular disease remains a significant global health burden, making it crucial to construct accurate risk prediction models, Analyzing a large clinical dataset, this study evaluates performance of logistic regression and random forest models in predicting cardiovascular and cerebrovascular diseases, data are divided into training and testing sets, and multiple indicators such as accuracy, precision, recall, F1 score, and area under ROC curve (AUC) are used to measure model's effectiveness, results show that both models exhibited good predictive performance, with slightly better accuracy in random forest classification and outstanding discriminative ability in logistic regression (AUC of 0.78), Studying ensemble models can bring marginal performance improvements, but traditional statistical methods still have significant advantages and interpretability in clinical risk prediction, These conclusions provide clinically actionable guidance for clinicians and researchers to select appropriate machine learning models—such as preferring logistic regression for interpretable risk stratification or random forest for slightly higher accuracy—when screening for cardiovascular and cerebrovascular diseases in clinical practice.


